Unmasked: Inside The Secret Operations Of CBEX In Nigeria – Sh*cking New Revelations Surface

The Securities and Exchange Commission (SEC) has officially declared that Crypto Bridge Exchange (CBEX) is not licensed to operate as a digital asset exchange in Nigeria.....KINDLY READ THE FULL STORY HERE▶

In a public advisory issued on Thursday, April 17, the SEC warned Nigerians against engaging in any financial transactions with the platform. It revealed that CBEX—operating under aliases such as ST Technologies International Ltd and Smart Treasure/Super Technology—has been unlawfully soliciting investments from the public with promises of highly unrealistic returns.

“CBEX and its associated entities are not registered by the Commission to function as a digital asset exchange, raise capital from the public, or perform any other activity within Nigeria’s capital markets,” the SEC clarified.

The platform reportedly promised investors 100% returns within 30 days, a claim that has raised serious regulatory concerns. Following growing complaints, CBEX’s business operations are now under investigation for fraudulent activities and misrepresentation.

Preliminary findings indicate that CBEX has been fabricating withdrawal records to hide widespread issues users face when trying to access their funds. Additionally, the platform had engaged in aggressive promotions designed to give a false impression of legitimacy. It is also alleged to have shut down its physical offices amid mounting scrutiny and investor complaints.

The SEC emphasized that under Section 196 of the Investments and Securities Act 2025, it is collaborating with relevant law enforcement agencies to enforce sanctions against CBEX, its affiliates, and its promoters.

Director-General Emomotimi Agama stressed that the Commission is launching a robust crackdown on illegal and unregistered investment platforms, many of which operate like Ponzi schemes.

The public is urged to exercise caution and avoid investment schemes that promise unrealistic returns or lack proper regulatory approval.